Dr. Doulatov is an Associate Professor at the University of Washington. His laboratory investigates how normal hematopoietic stem cells (HSCs) transform into blood cancers. As an undergraduate at UCLA with Dr. Jeff Miller, he discovered a new class of retroelements. As a Ph.D. student with Dr. John Dick at the University of Toronto, he helped establish the “roadmap” of the human HSC and progenitor hierarchy. As a postdoctoral fellow with Dr. George Daley at Harvard, he identified methods to promote HSC development from induced pluripotent stem cells (iPSCs). These advances have enabled the use of iPSCs as a platform for disease modeling and drug screens, leading to the discovery of a drug for inherited anemia. The Doulatov laboratory is using human iPSCs and HSCs to discover how oncogenic mutations cooperate to transform normal stem cells into leukemias. His long-term goal is to develop treatments that target malignant stem cells leading to lasting remissions for patients.